ScholarLens Back to search
1997•ACP Journal ClubRequires access

Continuing anticoagulants for recurrent venous thromboembolism was better than 6-month anticoagulant therapy

Paul R. Eisenberg, Paul R. Eisenberg

Open publisher page 0 citations

Abstract

Source Citation Schulman S, Granqvist S, Holmström M, et al., and the Duration of Anticoagulation Trial Study Group. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med. 1997 Feb 6;336:393-8.

About this research paper

What this paper is about

Source Citation Schulman S, Granqvist S, Holmström M, et al., and the Duration of Anticoagulation Trial Study Group. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med. 1997 Feb 6;336:393-8.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Source Citation Schulman S, Granqvist S, Holmström M, et al., and the Duration of Anticoagulation Trial Study Group. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med. 1997 Feb 6;336:393-8.

Key concepts: Medicine, Venous thromboembolism, Anticoagulant therapy, Oral anticoagulant, Anticoagulant, Randomized controlled trial, Warfarin, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Continuing anticoagulants for recurrent venous thromboembolism was better than 6-month anticoagulant therapy — Research Paper | ScholarLens